Matches in Wikidata for { <http://www.wikidata.org/entity/Q92990249> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q92990249 description "article scientifique publié en 2020" @default.
- Q92990249 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92990249 description "scientific article published on 28 January 2020" @default.
- Q92990249 description "wetenschappelijk artikel" @default.
- Q92990249 description "наукова стаття, опублікована 28 січня 2020" @default.
- Q92990249 name "Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance" @default.
- Q92990249 name "Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance" @default.
- Q92990249 type Item @default.
- Q92990249 label "Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance" @default.
- Q92990249 label "Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance" @default.
- Q92990249 prefLabel "Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance" @default.
- Q92990249 prefLabel "Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance" @default.
- Q92990249 P1433 Q92990249-18BFFCB4-F240-4FCB-ACAE-08077C06D986 @default.
- Q92990249 P1476 Q92990249-EFDC89CD-5DEE-418E-A5A9-7B33808D8444 @default.
- Q92990249 P2093 Q92990249-4108924B-9F62-4E99-A506-772D30E5E2B5 @default.
- Q92990249 P2093 Q92990249-543B6553-E011-4ABE-B113-5EB2CE562689 @default.
- Q92990249 P2093 Q92990249-99B50588-289B-4F61-A6F1-3D9D8D054A29 @default.
- Q92990249 P2093 Q92990249-9B82FE9A-46AC-4D79-8BAB-8BA3E1FB2D76 @default.
- Q92990249 P2093 Q92990249-A98644F2-0B25-4789-9869-B98D5B72936C @default.
- Q92990249 P31 Q92990249-D381255F-5C54-4A91-B015-ACFC3F9DB9A3 @default.
- Q92990249 P356 Q92990249-784C2AFD-59EC-42E5-8B3F-F28F7D9F9507 @default.
- Q92990249 P50 Q92990249-8267A773-2998-4C7A-98BA-FE935ABF8397 @default.
- Q92990249 P577 Q92990249-B0882315-1CC9-419C-939E-84478252D2E7 @default.
- Q92990249 P698 Q92990249-5050E528-4D87-4A8D-BC88-D53888958006 @default.
- Q92990249 P356 JPEN.1732 @default.
- Q92990249 P698 31990087 @default.
- Q92990249 P1433 Q6295717 @default.
- Q92990249 P1476 "Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance" @default.
- Q92990249 P2093 "Chris N Barnes" @default.
- Q92990249 P2093 "Cristina Almansa" @default.
- Q92990249 P2093 "Deanna Nguyen" @default.
- Q92990249 P2093 "Karen L Jones" @default.
- Q92990249 P2093 "Marianne J Chapman" @default.
- Q92990249 P31 Q13442814 @default.
- Q92990249 P356 "10.1002/JPEN.1732" @default.
- Q92990249 P50 Q88310543 @default.
- Q92990249 P577 "2020-01-28T00:00:00Z" @default.
- Q92990249 P698 "31990087" @default.